# Aeonian Pharmaceuticals

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/aeonian-pharmaceuticals

- Industry: Biotechnology
- Headquarters: San Francisco, US
- Website: www.aeonianpharma.com
- Latest round: Seed (Dec 11, 2017)
- Investors on record: 1

## About

Aeonian Pharmaceuticals, Inc. is engaged in developing innovative therapies focused on enhancing patient outcomes through advanced clinical trial solutions.Aeonian Pharmaceuticals, Inc. specializes in developing therapeutic solutions aimed at improving patient healthcare outcomes. The company is headquartered in San Francisco, US. Aeonian Pharmaceuticals, Inc. received seed funding in December 2017, led by Apollo Health Ventures, to support its clinical development initiatives.Aeonian Pharmaceuticals, Inc. provides Interactive Response Technology (IRT) solutions that streamline clinical trial management. Their primary offerings include Randomization Trial Supply Management (RTSM) systems, which enhance participant enrollment, randomization, and drug supply chain management while minimizing data errors. The technology serves pharmaceutical companies, clinical research organizations, and healthcare institutions across North America, Europe, and Asia-Pacific, facilitating global clinical trials with effective solutions.Aeonian Pharmaceuticals, Inc. generates revenue through B2B transactions primarily with pharmaceutical and biotech firms for clinical trial support. Revenue is derived from IRT system implementations, including subscriptions for ongoing access and support, tailored to the complexity of each trial. Their RTSM solutions are central to their revenue strategy, as clients require reliable platforms for managing trial logistics and ensuring data integrity.Following the seed funding raised in December 2017, Aeonian Pharmaceuticals, Inc. plans to accelerate the clinical development of its lead programs. The company aims to explore new markets and geographical regions, with specific targets planned for expansion by 2025. The funding will be utilized to support these initiatives, facilitating advancement in their clinical programs.

## Funding rounds

- Seed, Dec 11, 2017 — Apollo Health Ventures

## Investors

- Apollo Health Ventures (https://capitalatlas.ai/funds/apollo-health-ventures) — Seed